New Study Published In Molecular Medicine Reports That Novel Agent Decreases Neuropathic Pain In Patients With Type 2 Diabetes

Reuters
December 15. 2014
New Study Published In Molecular Medicine Reports That Novel Agent Decreases Neuropathic Pain In Patients With Type 2 Diabetes

Dr. Kevin J. Tracey, President, Feinstein Institute for Medical Research

Read this Story

Focus onHealth TV

Watch Focus onHealth, Northwell Health's TV show. It's the healthy way to stay informed!